We aspire to bring our cutting-edge liquid biopsy technology for genotyping and disease monitoring to patients worldwide.
Joined April 2024
- Tweets 37
- Following 60
- Followers 8
- Likes 7
11 Photos and videos
Ovarian cancer symptoms are easily missed → most cases caught at stage III–IV.
We're working on a liquid biopsy solution for early detection.
📩 Contact us for more info
🌐 Visit our website: liqomics.com
1
1
21
Looking ahead to meaningful conversations with hematology and oncology colleagues, industry partners, physicians, and patients.
One goal: advancing precision medicine to transform care and treatment pathways.
liqomics.com
Let's talk.
1
1
96
Clarity. Data. Frontiers. Value.
All in one place.
👉 liquidbiopsyinfo.com
For patients. For clinicians. For researchers. For everyone.
1
24
liquidbiopsyinfo.com - Clarity for patients. Data for clinicians. Frontiers for researchers. Unique value for everyone.
1
20
New US diagnostic recommendations for lymphoma: Sven Borchmann explains the impact of updated NCCN Guidelines - global oncology gold standard. For the first time, ctDNA-MRD blood testing is recommended for DLBCL patients. liqomics.com/en/news/newslet…
1
37
Proud to share liquidbiopsyinfo.com - a completely free platform designed to open up the world of liquid biopsy in cancer diagnostics. Whether you're a researcher, clinician, or simply passionate about the future of oncology, we’ve broken down the complexity of liquid biopsy.
1
21
Particularly striking is the finding that 89% of US oncologists anticipate a sharp rise in complexity over the next three years, driven by new therapies and increasing diagnostic data. Europe, meanwhile, has yet to fully enter that phase. Read more: linkedin.com/posts/sven-borc…
1
16
Only 3% of healthcare spending in Germany goes to prevention - yet early detection saves lives and costs. MRD testing shows how prevention and precision medicine can work together. Time to move from repair medicine to real prevention. Read the full article
linkedin.com/posts/sven-borc…
1
19
What if a simple blood draw could detect and monitor cancer? The key is ctDNA. We're exploring the advances making this the future of oncology. Read the full article and join the conversation: liqomics.com/en/news/cancer-… #ctDNA #LiquidBiopsy #CancerDiagnostics
1
18
Our Founder & Managing Director, Sven Borchmann, MD/PhD, challenges a core assumption in clinical practice: "Are we treating patients we shouldn't? I think we are asking the wrong questions!"
Here is a new article: linkedin.com/posts/sven-borc…
Take a look and share your perspective.
1
31
Last week, our managing director Sven Borchmann presented at the 3rd International Symposium on Minimal Residual Disease in Haematological Malignancies. He shared some thoughts here: linkedin.com/feed/update/urn…
1
30
Extremely interesting paper with implications for cfDNA diagnostic assays in cancer and beyond: science.org/doi/10.1126/scie…
#LiquidBiopsy #CancerDetection #PrecisionMedicine #cfDNA #CancerResearch #Diagnostics
2
32
Today, our Managing Director Sven Borchmann MD/PhD gave a talk on ctDNA sequencing and MRD assessment in lymphoma at the European Lymphoma Institute (ELI) meeting in Uppsala, Sweden. Check out his post about the talk: linkedin.com/posts/sven-borc…
2
21
New Opportunity at Liqomics
Join Liqomics as a Medical Sales & Business Development Representative. If you love Sales & Marketing, speak German and English and get excited about bringing cutting-edge technology into clinical practice, have a look: bit.ly/46te2RY.
2
18
Entdecken Sie LymphoVista - unseren sensitiven Liquid Biopsy Test für die MRD-Detektion bei Lymphomen. Nutzen Sie präzise ctDNA-Analysen zur individuellen Therapieüberwachung und Rezidiv-Erkennung. Details finden Sie unter: bit.ly/4n8A3ws
1
16
Exciting news! Our Fragmentomics by LIQOMICS project is funded by ZukunftBIO.NRW! We're advancing liquid biopsy diagnostics, transforming precision medicine, and enabling better cancer care. Learn more: liqomics.com/fragmentomics-b…
1
36
✨ Big news from @ASH_hematology !
LymphoVista® HL Assay is revolutionizing #MRD detection in Hodgkin Lymphoma. Learn how it's shaping precision medicine. 🧬
🔗 Read more: liqomics.com/lymphovista-hl-…
#HodgkinLymphoma #LymphoVista #Oncology
1
59
Exciting News! @ismrc2025 is happening in Nice, France! 🌍 Join top experts in oncology, explore cutting-edge research, and enjoy the French Riviera. Don’t miss it! 🔗 Register now: [ismrc-symposium.eu/registrat…] #ISMRC2025
2
68